“…Compared to other dissolving microneedles, hyaluronic acid (HA)-, alginate-and chitosan-based microneedles have recently been used in cancer immunotherapy, due to their adjuvant functions. [90][91][92][93][94][95] Low-molecular-weight (LMW) HA (100-500 kDa) has been shown to engage a receptor complex comprising CD44 and toll-like receptors (TLRs), inducing cytokine release, and HA oligomers (with fewer than 10 HA disaccharides) have been reported to function as damage-associated molecular pattern (DAMP) molecules by specifically binding TLR2 and TLR4. 96,97 A HA-based microneedle array for the delivery of anti-PD1 antibody (aPD1) and 1-methyl-DL-tryptophan (1-MT) to melanoma was also produced 88 (Fig.…”